You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peripheral Blood Stem Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
Has Results
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

Recruiting
  • Granuloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • sargramostim
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 3, 2022

    Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

    Completed
    Has Results
    • Multiple Myeloma
    • busulfan, melphalan and fludarabine
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 4, 2021

    Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

    Available
    • Benign Neoplasm
    • +3 more
    • Bone Marrow Transplantation
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 9, 2021

    Proliferative Potential of H-PBSC Based on Demographics and

    Recruiting
    • Healthy
    • Cellular analysis
    • Gulf Breeze, Florida
      Andrews Research & Education Foundation
    Oct 6, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Fanconi Anemia Trial in Paris (G-CSF, Plerixafor)

      Completed
      • Fanconi Anemia
      • Paris, France
        Hôpital necker-Enfants malades
      Dec 20, 2021

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +14 more
      • Aldesleukin
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 31, 2022

      Cartilage Injury Trial in Beijing (genetic, procedure, combination product)

      Not yet recruiting
      • Cartilage Injury
      • autologous peripheral blood mesenchymal stem cell
      • +3 more
      • Beijing, Beijing, China
        Institute of Sports Medicine, Peking University Third Hospital
      Jun 25, 2021

      Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

      Not yet recruiting
      • Adenosine Deaminase Severe Combined Immune Deficiency
      • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
      • (no location specified)
      Jun 20, 2022

      Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

      Completed
      • Chronic Myelogenous Leukemia
      • +9 more
      • Atlanta, Georgia
        Northside Hospital
      Apr 4, 2022

      Sickle Cell Disease Trial in Los Angeles (ßAS3-FB vector transduced peripheral blood CD34+ cells)

      Recruiting
      • Sickle Cell Disease
      • βAS3-FB vector transduced peripheral blood CD34+ cells
      • Los Angeles, California
        University of California, Los Angeles (UCLA)
      Apr 9, 2022

      AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))

      Terminated
      • AIDS-related Lymphoma
      • HIV Infections
      • PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Sep 4, 2022

      Multiple Sclerosis Trial (Hematopoietic stem cell transplantation)

      Enrolling by invitation
      • Multiple Sclerosis
      • Hematopoietic stem cell transplantation
      • (no location specified)
      Jan 26, 2021

      Healthy Trial in United States (Filgrastim)

      Recruiting
      • Healthy
      • Duarte, California
      • +19 more
      Mar 7, 2022

      Healthy Trial in Abu Dhabi (Nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).)

      Completed
      • Healthy
      • Nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).
      • Abu Dhabi, United Arab Emirates
        Abu Dhabi Stem Cells Center
      Nov 21, 2020

      Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

      Recruiting
      • Systemic Sclerosis
      • +3 more
      • Pittsburgh, Pennsylvania
      • +2 more
      Dec 17, 2021

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023